v3.25.3
Equity Investees (Consolidated Financial Statements Related to Equity Investees) (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]        
Genesis’ share of operating earnings $ 14,411,000 $ 15,200,000 $ 46,365,000 $ 50,986,000
Amortization of differences attributable to Genesis’ carrying value of equity investments (3,566,000) (3,566,000) (10,698,000) (10,698,000)
Equity in earnings of equity investees 10,845,000 11,634,000 35,667,000 40,288,000
Distributions received $ 16,078,000 $ 18,488,000 $ 52,587,000 $ 58,829,000